Table 10.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1993 to 2002

Recipients with Intestine Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Functioning Graft at Discharge		20	16	33	35	47	48	49	59	88	89
With Immunosuppression Info		17	16	31	24	46	48	49	59	88	89
Corticosteroids	Category Usage	100.0%	100.0%	93.5%	100.0%	97.8%	97.9%	93.9%	96.6%	79.5%	64.0%
	Steroids	100.0%	100.0%	93.5%	100.0%	97.8%	97.9%	93.9%	96.6%	79.5%	64.0%
Cyclosporine	Category Usage	0.0%	6.3%	6.5%	0.0%	2.2%	8.3%	4.1%	0.0%	0.0%	0.0%
	Cyclosporin	0.0%	6.3%	6.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	0.0%	0.0%	0.0%	0.0%	4.2%	0.0%	0.0%	0.0%	0.0%
	Neoral	0.0%	0.0%	0.0%	0.0%	2.2%	4.2%	4.1%	0.0%	0.0%	0.0%
Tacrolimus	Category Usage	100.0%	75.0%	93.5%	91.7%	95.7%	89.6%	95.9%	94.9%	98.9%	95.5%
	FK506	100.0%	75.0%	93.5%	91.7%	95.7%	89.6%	95.9%	94.9%	98.9%	95.5%
Antimetabolites	Category Usage	11.8%	25.0%	29.0%	58.3%	54.3%	35.4%	24.5%	20.3%	10.2%	11.2%
	Azathioprine	11.8%	25.0%	22.6%	20.8%	10.9%	6.3%	6.1%	5.1%	6.8%	0.0%
	Mycophenolate mofetil	0.0%	0.0%	6.5%	37.5%	45.7%	33.3%	18.4%	18.6%	3.4%	11.2%
Other	Category Usage	0.0%	0.0%	6.5%	8.3%	4.3%	0.0%	2.0%	39.0%	21.6%	19.1%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.0%	39.0%	21.6%	19.1%
	Cytoxan	0.0%	0.0%	6.5%	8.3%	4.3%	0.0%	0.0%	0.0%	0.0%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.